Logos Global Management LP Passage Bio, Inc. Transaction History

Logos Global Management LP

  • $1.07 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.24 - $10.2 $780,062 - $1.28 Million
-125,010 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$16.24 - $29.83 $3.56 Million - $6.55 Million
-219,428 Reduced 63.71%
125,010 $2.19 Million
Q2 2020

Aug 14, 2020
SELL
$14.59 - $36.07 $3.78 Million - $9.34 Million
-258,900 Reduced 42.91%
344,438 $8.47 Million
Q1 2020

May 15, 2020
BUY
$8.86 - $22.2 $5.35 Million - $13.4 Million
603,338 New
603,338 $8.96 Million

Others Institutions Holding PASG

# of Institutions
44
Shares Held
28.3M
Call Options Held
8.3K
Put Options Held
400
View Full List

About Passage BIO, Inc.

PASG Quotes by TradingView
  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $35.4M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email